Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Naturalistic Observational Study to Evaluate Efficacy of 2nd-generation Antipsychotics and Remission Status for Patients With Schizophrenia / Schizoaffective Disorder

NCT00809731 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00809731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00809731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Naturalistic Observational Study to Evaluate Efficacy of 2nd-generation Antipsychotics and Remission Status for Patients With Schizophrenia / Schizoaffective Disorder
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
December 31, 2008
Completion date
September 30, 2010
Enrollment
490 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia